Form 4 for QURE uniQure N.V.
Accepted 2026-06-12 18:04:09 ET · period of report 2026-06-10 · accession 0000904454-26-000350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-12 18:04 | 2026-06-10 | QURE | Gut Robert | Dir | M - OptEx | $16.04 | +2,645 | 35.0K | +8% | +$42.4K |
| DMT | 2026-06-12 18:04 | 2026-06-10+ | QURE | Gut Robert | Dir | S - Sale+OE | $26.32 | -10.3K | 32.3K | -24% | -$270.5K |
| DT | 2026-06-12 18:04 | 2026-06-10 | QURE | Gut Robert | Dir | A - Grant | $0.00 | +7,550 | 35.0K | +28% | $0 |
| DT | 2026-06-12 18:04 | 2026-06-10 | QURE | Gut Robert | Dir | M - OptEx | $0.00 | -2,645 | 0 | -100% | $0 |
| DT | 2026-06-12 18:04 | 2026-06-10 | QURE | Gut Robert | Dir | A - Grant | $0.00 | +14.0K | 14.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-10 | M | A | 2,645 | $16.04 | 34,987 | D | — | — | (F1) The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
| 2 | Common | Ordinary Shares | 2026-06-10 | S | D | 2,645 | $26.07 | 32,342 | D | — | — | (F1) The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. |
| 3 | Common | Ordinary Shares | 2026-06-10 | S | D | 3,127 | $26.03 | 29,215 | D | — | — | (F1) The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. |
| 4 | Common | Ordinary Shares | 2026-06-10 | S | D | 1,780 | $26.05 | 27,435 | D | — | — | (F1) The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. |
| 5 | Common | Ordinary Shares | 2026-06-10 | A | A | 7,550 | $0.00 | 34,985 | D | — | — | (F5) Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. |
| 6 | Common | Ordinary Shares | 2026-06-11 | S | D | 2,726 | $27.06 | 32,259 | D | — | — | (F6) The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. (F6) The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-06-10 | M | D | 2,645 | $0.00 | 0 | D | $16.04 · — to 2032-02-24 | 2,645 Ordinary Shares | (F1) The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. (F8) The Stock Option vested in full on February 24, 2023. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-06-10 | A | A | 13,980 | $0.00 | 13,980 | D | $26.82 · — to 2036-06-10 | 13,980 Ordinary Shares | (F9) The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. |